Resurrect Therapeutics

Pressroom

Announcements from Resurrect Therapeutics, newest first.

Media contact james.michael.eldeiry@gmail.com

Poster

Systematic Identification of Recoverable Oncology Assets Hidden Among Terminated Clinical Programs: Transforming Drug Abandonment into a Searchable Source of Precision Therapeutic Opportunity.

Poster by James M. El-Deiry, JD; John R. El-Deiry, MBA; and Wafik S. El-Deiry, MD, PhD, FACP.

We created a digital workflow that utilizes advanced data analysis to build an evidence-backed investigation around each discontinued asset, with recommended FDA-approval and commercialization paths.

Download the poster (PDF)

October 21, 2026
Resurrect Therapeutics, Inc. Sponsors 2026 WIN Symposium in Rhode Island, Showcases AI-Powered Drug Discovery Platform, and Receives Enthusiastic Response from Scientific Community
[Providence, Rhode Island, October 21, 2026] – Resurrect Therapeutics, Inc. an innovative biotechnology intelligence platform leveraging artificial intelligence to identify and evaluate opportunities to revive discontinued drug development programs, announced its participation as a sponsor of the 2026 WIN Symposium, held October 2–3, 2026 at the Rhode Island Convention Center in Providence, Rhode Island.
Download the original press release (PDF)

Poster

Resurrect Therapeutics, Inc. Sponsors 2026 WIN Symposium in Rhode Island, Showcases AI-Powered Drug Discovery Platform, and Receives Enthusiastic Response from Scientific Community